Osteoarthritis (OA) is an inflammatory joint disease causing progressive disability in the elderly. Reactive oxygen species (ROS) activate the NLRP3 inflammasome, leading to the secretion of proinflammatory IL-1β and IL-18. Nrf2, a transcription factor, regulates antioxidant enzyme expression. Researchers investigated the underlying mechanism of OA development by investigating NLRP3, ASC, Nrf2, and HO-1 expression in synovia and their regulatory networks. Results showed cartilage destruction and subchondral bone sclerosis in OA patients and OA model rats. The study found that ROS-induced oxidative stress may be the main cause of NLRP3 inflammasome activation and subsequent release of downstream factors during OA development. The discovery of a novel role of Nrf2/HO-1 signaling in NLRP3 production may facilitate the prevention and treatment of OA. Read more..,.Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis - PubMed (nih.gov)
**********
Magnolol attenuates depressive-like behaviors by polarizing microglia towards the M2 phenotype through the regulation of Nrf2/HO-1/NLRP3 signaling pathway
Magnolol (MA) has been found to have an anti-depressant effect by inhibiting inflammation. However, its effect on microglia polarization in chronic unpredictable mild stress (CUMS)-induced depression remains unclear. A study conducted on mice and BV2 cells revealed that MA treatment relieved depressive behaviors, suppressed pro-inflammatory cytokines, promoted anti-inflammatory cytokines, and induced microglia-specific indicators. MA upregulated Nrf2 expression, reduced ROS concentration, promoted Nrf2 nucleus translocation, and prevented Nrf2 ubiquitination. The study concluded that MA attenuated CUMS-stimulated depression by inhibiting M1 polarization and inducing M2 polarization via Nrf2/HO-1/NLRP3 signaling. Magnolol attenuates depressive-like behaviors by polarizing microglia towards the M2 phenotype through the regulation of Nrf2/HO-1/NLRP3 signaling pathway - PubMed (nih.gov)
**********
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Oxidative stress (OS) is a key contributor to PD, with genetic and environmental factors contributing to its pathogenesis. Nrf2, a transcription factor, activates protective genes like heme oxygenase-1 (HO-1), which protect cells from OS. Recent studies suggest that bioactive compounds can activate Nrf2/ARE and ameliorate PD-associated neurotoxin, suggesting pharmacological modulation of this signaling pathway as a potential therapeutic target. Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease - PubMed (nih.gov)
**********
α-lipoic acid ameliorates hepatotoxicity induced by chronic ammonia toxicity in crucian carp (Carassius auratus gibelio) by alleviating oxidative stress, inflammation and inhibiting ERS pathway
High environment ammonia (HEA) threatens aquatic animals and human health. α-lipoic acid, an antioxidant, can mitigate oxidative stress and protect against chronic ammonia stress in crucian carp. Supplementation with α-lipoic acid induces humoral immunity, alleviates oxidative stress injury, and reduces liver injury induced by ammonia poisoning. α-lipoic acid ameliorates hepatotoxicity induced by chronic ammonia toxicity in crucian carp (Carassius auratus gibelio) by alleviating oxidative stress, inflammation and inhibiting ERS pathway - PubMed (nih.gov)
**********

Comments
Post a Comment